Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 2
2004 3
2007 3
2009 2
2010 1
2014 3
2015 4
2018 1
2019 1
2020 2
2022 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Blurred vision.
Stalenhoef AF, van Lith-Verhoeven JJ. Stalenhoef AF, et al. Among authors: van lith verhoeven jj. Neth J Med. 2007 Dec;65(11):461-2. Neth J Med. 2007. PMID: 18079572 Free article. No abstract available.
Dominant cystoid macular dystrophy.
Saksens NT, van Huet RA, van Lith-Verhoeven JJ, den Hollander AI, Hoyng CB, Boon CJ. Saksens NT, et al. Among authors: van lith verhoeven jj. Ophthalmology. 2015 Jan;122(1):180-91. doi: 10.1016/j.ophtha.2014.07.053. Epub 2014 Sep 26. Ophthalmology. 2015. PMID: 25267528
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.
Gabrielle PH, Nguyen V, Arnould L, Viola F, Zarranz-Ventura J, Barthelmes D, Creuzot-Garcher C, Gillies M; Fight Retinal Blindness! Study Group. Gabrielle PH, et al. Ophthalmol Retina. 2022 Nov;6(11):1044-1053. doi: 10.1016/j.oret.2022.05.008. Epub 2022 May 16. Ophthalmol Retina. 2022. PMID: 35589075 Free article.
Scrutinizing pathogenicity of the USH2A c.2276 G > T; p.(Cys759Phe) variant.
Reurink J, de Vrieze E, Li CHZ, van Berkel E, Broekman S, Aben M, Peters T, Oostrik J, Neveling K, Venselaar H, Ramos MG, Gilissen C, Astuti GDN, Galbany JC, van Lith-Verhoeven JJC, Ockeloen CW, Haer-Wigman L, Hoyng CB, Cremers FPM, Kremer H, Roosing S, van Wijk E. Reurink J, et al. Among authors: van lith verhoeven jjc. NPJ Genom Med. 2022 Jun 7;7(1):37. doi: 10.1038/s41525-022-00306-z. NPJ Genom Med. 2022. PMID: 35672333 Free PMC article.
Achieving balance in the treatment and monitoring of neovascular age-related macular degeneration in the real world: lessons from the Netherlands cohort of the AURA study.
van Asten F, de Jong-Hesse Y, van Lith-Verhoeven JJC, Verbraak FD, Vromans JGF, Lau NC, Altemark A, Hoyng CB. van Asten F, et al. Among authors: van lith verhoeven jjc. Acta Ophthalmol. 2019 Mar;97(2):e323-e324. doi: 10.1111/aos.13946. Epub 2018 Oct 14. Acta Ophthalmol. 2019. PMID: 30318723 Free article. No abstract available.
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized Trial.
Vader MJC, Schauwvlieghe AME, Verbraak FD, Dijkman G, Hooymans JMM, Los LI, Zwinderman AH, Peto T, Hoyng CB, van Leeuwen R, Vingerling JR, Moll AC, van Lith-Verhoeven JJC, Dijkgraaf MGW, Schlingemann RO; Bevacizumab and Ranibizumab in Diabetic Macular Edema Study Group. Vader MJC, et al. Among authors: van lith verhoeven jjc. Ophthalmol Retina. 2020 Aug;4(8):777-788. doi: 10.1016/j.oret.2020.02.008. Epub 2020 Feb 27. Ophthalmol Retina. 2020. PMID: 32362552 Free article. Clinical Trial.
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial.
Vader MJC, Schauwvlieghe AME, Verbraak FD, Dijkman G, Hooymans JMM, Los LI, Zwinderman AH, Peto T, Hoyng CB, van Leeuwen R, Vingerling JR, de Jong-Hesse Y, van Lith-Verhoeven JJC, Dijkgraaf MGW, Schlingemann RO; Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) Study Group. Vader MJC, et al. Among authors: van lith verhoeven jjc. Ophthalmol Retina. 2020 Jun;4(6):576-587. doi: 10.1016/j.oret.2019.12.019. Epub 2020 Jan 7. Ophthalmol Retina. 2020. PMID: 32107188 Free article. Clinical Trial.
23 results